T1	Participants 64 111	the LIPID Trial for Secondary Prevention of IHD
T2	Participants 371 487	coronary mortality in patients with a previous myocardial infarction or unstable angina-ischemic heart disease (IHD)
T3	Participants 489 597	It is planned to run for at least five years with 9014 patients from 85 centers in Australia and New Zealand
